Stocks
Allogene Therapeutics (ALLO) R&D US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| R&D, bln rub | 144.5 | 193.0 | 220.2 | 256.4 | 242.9 | 194.8 | |||
| Changes by years, y/y, % | -5% | +34% | +14% | +16% | -5% | +9.9% | |||
Allogene Therapeutics. R&D, bln rub
Allogene Therapeutics. R&D, changes, %
Allogene Therapeutics. R&D, sum by quarters, bln rub
Allogene Therapeutics (ALLO) R&D US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| R&D, bln rub | 46.0 | 54.7 | 48.7 | 46.7 | 44.7 | 194.8 | ||
| Changes by years, y/y, % | -28% | -28% | -39% | -25% | -3% | |||
| Changes by quarters, q/q, % | -26% | +19% | -11% | -4% | -4% | |||
